Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Acne is an important sign of androgen excess disorders in women.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Topical eye β-blockers may cause hair loss.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Moderately high prolactin levels do not cause hair loss in women.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.